Churchville, PA, United States of America

Rajiv Haribhakti

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Sanofi-Aventis. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajiv Haribhakti. Retrieved from https://idiyas.com/inventor/rajiv-haribhakti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rajiv Haribhakti: Innovator in Pharmaceutical Formulations

Introduction

Rajiv Haribhakti is a notable inventor based in Churchville, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications. His work has led to advancements that benefit patients and healthcare providers alike.

Latest Patents

Rajiv holds a patent for a fexofenadine suspension formulation. This invention is directed to an aqueous pharmaceutical suspension of fexofenadine zwitterionic dihydrate Form I. This formulation aims to improve the delivery and effectiveness of the medication.

Career Highlights

Rajiv is currently employed at Sanofi-Aventis, a leading global biopharmaceutical company. His role involves research and development, where he applies his expertise to create innovative pharmaceutical solutions. His dedication to improving drug formulations has been a hallmark of his career.

Collaborations

Throughout his career, Rajiv has collaborated with talented professionals, including Kazimierz Chrzan and Matthew Mermey. These collaborations have fostered an environment of innovation and creativity, leading to successful outcomes in their projects.

Conclusion

Rajiv Haribhakti's contributions to pharmaceutical formulations exemplify the impact of innovation in healthcare. His patent for fexofenadine suspension formulation showcases his commitment to improving patient care through effective medication delivery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…